167 related articles for article (PubMed ID: 35149132)
1. Paeonia lactiflora extract improves the muscle function of mdx mice, an animal model of Duchenne muscular dystrophy, via downregulating the high mobility group box 1 protein.
Sim I; Jang J; Song J; Lee J; Lim H; Lee HJ; Hwang G; Kwon YV; Lee D; Yoon Y
J Ethnopharmacol; 2022 May; 289():115079. PubMed ID: 35149132
[TBL] [Abstract][Full Text] [Related]
2. Paeonia lactiflora extract suppresses cisplatin-induced muscle wasting via downregulation of muscle-specific ubiquitin E3 ligases, NF-κB signaling, and cytokine levels.
Jang J; Lee H; Song J; Bae T; Park M; Kwon YV; Lee D; Yoon Y
J Ethnopharmacol; 2021 Feb; 266():113403. PubMed ID: 32971160
[TBL] [Abstract][Full Text] [Related]
3. Paeonia lactiflora root extract suppresses cancer cachexia by down-regulating muscular NF-κB signalling and muscle-specific E3 ubiquitin ligases in cancer-bearing mice.
Bae T; Jang J; Lee H; Song J; Chae S; Park M; Son CG; Yoon S; Yoon Y
J Ethnopharmacol; 2020 Jan; 246():112222. PubMed ID: 31505213
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
5. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
6. Weekly oral prednisolone improves survival and strength in male mdx mice.
Keeling RM; Golumbek PT; Streif EM; Connolly AM
Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
[TBL] [Abstract][Full Text] [Related]
7. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
8. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
9. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
[TBL] [Abstract][Full Text] [Related]
10. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
12. Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.
Huynh T; Uaesoontrachoon K; Quinn JL; Tatem KS; Heier CR; Van Der Meulen JH; Yu Q; Harris M; Nolan CJ; Haegeman G; Grounds MD; Nagaraju K
J Pathol; 2013 Oct; 231(2):223-35. PubMed ID: 23794417
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T
Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.
Hindi SM; Sato S; Choi Y; Kumar A
Hum Mol Genet; 2014 Mar; 23(6):1492-505. PubMed ID: 24163132
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.
Giordano C; Mojumdar K; Liang F; Lemaire C; Li T; Richardson J; Divangahi M; Qureshi S; Petrof BJ
Hum Mol Genet; 2015 Apr; 24(8):2147-62. PubMed ID: 25552658
[TBL] [Abstract][Full Text] [Related]
17. Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.
Benny Klimek ME; Sali A; Rayavarapu S; Van der Meulen JH; Nagaraju K
PLoS One; 2016; 11(5):e0155944. PubMed ID: 27213537
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
Altamirano F; Valladares D; Henríquez-Olguín C; Casas M; López JR; Allen PD; Jaimovich E
PLoS One; 2013; 8(12):e81222. PubMed ID: 24349043
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
20. A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation.
Sun Z; Xu D; Zhao L; Li X; Li S; Huang X; Li C; Sun L; Liu B; Jiang Z; Zhang L
Br J Pharmacol; 2022 Mar; 179(6):1237-1250. PubMed ID: 34553378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
